Trump Says Senate Bill Will Be ‘Very Good,’ But Needs ‘A Little Negotiation
"Obamacare is dead,' President Donald Trump said.
The independent source for health policy research, polling, and news.
32,741 - 32,760 of 112,425 Results
"Obamacare is dead,' President Donald Trump said.
It is not at all surprising that this bill is a terrible one,” League of Women Voters President Chris Carson said.
The Senate majority leader defended his bill after the details of it were released to lawmakers.
The Senate bill — once promised as a top-to-bottom revamp of the health bill passed by the House last month — instead maintains its structure, with modest adjustments.
A selection of opinions on health care from around the country.
Opinion writers across the country offer their thoughts on the Senate Republican health overhaul -- both in terms of style and substance -- while also examining a variety of health policy issues that are in play as Congress continues to contemplate sweeping changes to the nation's health care system.
Each week, KHN's Shefali Luthra finds interesting reads from around the Web.
Media outlets report on news from New Jersey, Ohio, Kansas, Utah, Georgia, Arizona and Massachusetts.
Today's other public health news stories cover maternal depression, the clinical trial system, the "brain-eating amoeba" case and autism.
More teens are also using contraception when they do have sex.
Stat reports that Mylan made the rebates conditional on states requiring that competitors' products get special requests by clinicians to be covered by Medicaid. In other news, the Food and Drug Administration says it will hold a hearing on efforts by drugmakers to impede competition, and an Australian drug company that is linked to a U.S. congressman gets approval for U.S. trials.
Although Anthem is withdrawing from some marketplaces, other companies are diving in. Media outlets look at the results of Wednesday's deadline for insurers to submit initial federal applications to offer 2018 marketplace plans.
Health insurers had until Wednesday to declare whether they planned to sell coverage next year on exchanges in most states.
“It would essentially write off a generation,” said Dr. Shawn Ryan, president of BrightView Health, a network of drug treatment clinics in Cincinnati. In other news on the opioid crisis, Missouri becomes the latest state to file suit against drugmaker Purdue Pharma, one in four people on Medicaid received opioids in 2015, and a county reveals its plan to curtail the epidemic.
These parts of the country already have more uninsured and underinsured people per capita than urban areas, and industry officials and community advocates are raising concerns about the future of small, local hospitals if Medicaid funding is reduced.
But they've been gathering talking points anyway.
President Donald Trump cajoled and courted reluctant House Republicans to vote "yes" on the bill last month. But those familiar with the process don't anticipate a repeat of that lobbying with the upper chamber.
The Senate majority leader has the option to cut off dilly-dallying if he deems it necessary, but it would be creating a new precedent for how the Senate operates. Republican leaders are also sending signals that they could use a rule to go around the parliamentarian's ruling on the legislation.
If they keep the language they may run afoul of Senate rules, but if they drop it, they could lose crucial conservative votes.
Repeating the experience of House GOP leaders, Senate leaders are stuck trying to make the bill palatable enough to woo moderates, while also keeping the conservatives happy. It's a tough line to walk, and no one is certain whether it's been accomplished.
© 2026 KFF